Clinical Trials Logo

Cholangiocarcinoma, Perihilar clinical trials

View clinical trials related to Cholangiocarcinoma, Perihilar.

Filter by:
  • Available  
  • Page 1

NCT ID: NCT03414489 Available - Cholangiocarcinoma Clinical Trials

Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)

Start date: n/a
Phase:
Study type: Expanded Access

This is an expanded access program (EAP) for eligible participants who do not qualify for participation in, or who are otherwise unable to access, the ongoing clinical trial ABC-108. This program is designed to provide access to ABC294640 (Yeliva ®) for treatment of cholangiocarcinoma (CCA) prior to approval by the local regulatory agency. Availability will depend on territory eligibility. Participating sites will be added as they apply for and are approved for the EAP. An oncologist must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.